南美洲和中美洲循环肿瘤细胞 (CTC) 诊断市场预测至 2028 年 - COVID-19 影响和区域技术分析(CTC 检测和富集方法、CTC 直接检测方法和 CTC 分析)、应用(临床/液体活检和研究)和最终用户(医院和诊所、研究和学术机构以及诊断中心)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 112    |    Report Code: TIPRE00028652    |    Category: Life Sciences

South and Central America Circulating Tumor Cell (CTC) Diagnostics Market

南部和南部中美洲循环肿瘤细胞 (CTC) 诊断市场预计将从 2021 年的 1.169 亿美元增至 2028 年的 2.14 亿美元。预计 2021 年至 2028 年该市场将以 9.0% 的复合年增长率增长。

< /span>

 

整个地区的卫生系统都见证了癌症患病率的大幅上升。因此,南美洲和南美洲的癌症患病率不断增加。中美洲正在推动对循环肿瘤细胞诊断的需求。循环肿瘤细胞的分析和检测有助于患者的早期诊断,预后有助于为这些患者确定准确的治疗方法。 CTC 诊断产品可检测各种类型的癌症,包括前列腺癌、乳腺癌、结直肠癌、肾癌、淋巴瘤、肺癌和黑色素瘤。近年来,由于 CTC 诊断技术在识别各种癌症风险和监测不同癌症治疗方面的可靠性和准确性,人们对 CTC 诊断的需求很高。

 

巴西、阿根廷、乌拉圭、智利、秘鲁和哥伦比亚受到第二波新冠病毒感染的打击。巴西记录了南美洲和中美洲因这种疾病死亡的大部分情况。此外,COVID-19 影响了接受癌症诊断、筛查和治疗的患者数量。 COVID-19 造成的严重破坏迫使大多数制药和生物技术公司将重点转向开发针对这种疾病的新疗法和诊断方法。此外,COVID-19 爆发造成的持续压力影响了供应链、公司运营和分销系统,包括其研发能力以及新颖产品的推出和服务。因此,在预测期内,COVID-19 大流行阻碍了 SCAM 的循环肿瘤细胞 (CTC) 诊断市场。

 

随着新的功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动循环肿瘤细胞(CTC)诊断市场的发展。南部和南部中美洲循环肿瘤细胞 (CTC) 诊断市场预计在预测期内将以良好的复合年增长率增长。

 

南&中美洲循环肿瘤细胞 (CTC) 诊断市场收入及 2028 年预测(百万美元)

 

< p>

南和南中美洲循环肿瘤细胞 (CTC) 诊断市场细分

 

作者技术

  • CTC检测及富集方法
  • CTC直接检测方法< /span>
  • CTC 分析

按应用

< /span>

  • 临床/液体活检
    • 风险评估
    • 筛查和监测
  • 研究
    • 癌症干细胞和肿瘤发生研究
    • 药物/疗法开发

最终用户

  • 医院和诊所
  • 研究和学术机构
  • 诊断中心

按国家

  • 巴西
  • 阿根廷
  • 南部和非洲其他地区中美洲

提及的公司

< ul>
  • Thermo Fisher Scientific Inc.
  • Stemcell Technologies Inc.
  • Qiagen
  • Advanced Cell Diagnostics, Inc.(Bio-Techne Corporation)
  • Fluxion Bioscience


  • South and Central America Circulating Tumor Cell (CTC) Diagnostics Strategic Insights

    Strategic insights for South and Central America Circulating Tumor Cell (CTC) Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/south-and-central-america-circulating-tumor-cell-ctc-diagnostics-market-strategic-framework.webp
    Get more information on this report

    South and Central America Circulating Tumor Cell (CTC) Diagnostics Report Scope

    Report Attribute Details
    Market size in 2021 US$ 116.9 Million
    Market Size by 2028 US$ 214.0 Million
    Global CAGR (2021 - 2028) 9.0%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By 技术
    • CTC检测和富集方法
    • CTC直接检测方法
    • CTC分析
    By 应用
    • 临床/液体活检
    • 研究
    By 最终用户
    • 医院和诊所
    • 研究和学术机构
    • 诊断中心
    Regions and Countries Covered 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区
    Market leaders and key company profiles
  • Thermo Fisher Scientific Inc.
  • Stemcell Technologies Inc.
  • Qiagen
  • Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
  • Fluxion Biosciences
  • Get more information on this report

    South and Central America Circulating Tumor Cell (CTC) Diagnostics Regional Insights

    The regional scope of South and Central America Circulating Tumor Cell (CTC) Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-circulating-tumor-cell-ctc-diagnostics-market-geography.webp
    Get more information on this report

    The List of Companies - South and Central America Circulating Tumor Cell (CTC) Diagnostics Market

    1. Thermo Fisher Scientific Inc.
    2. Stemcell Technologies Inc.
    3. Qiagen
    4. Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
    5. Fluxion Biosciences
    Frequently Asked Questions
    How big is the South and Central America Circulating Tumor Cell (CTC) Diagnostics Market?

    The South and Central America Circulating Tumor Cell (CTC) Diagnostics Market is valued at US$ 116.9 Million in 2021, it is projected to reach US$ 214.0 Million by 2028.

    What is the CAGR for South and Central America Circulating Tumor Cell (CTC) Diagnostics Market by (2021 - 2028)?

    As per our report South and Central America Circulating Tumor Cell (CTC) Diagnostics Market, the market size is valued at US$ 116.9 Million in 2021, projecting it to reach US$ 214.0 Million by 2028. This translates to a CAGR of approximately 9.0% during the forecast period.

    What segments are covered in this report?

    The South and Central America Circulating Tumor Cell (CTC) Diagnostics Market report typically cover these key segments-

  • 技术 (CTC检测和富集方法, CTC直接检测方法, CTC分析)
  • 应用 (临床/液体活检, 研究)
  • 最终用户 (医院和诊所, 研究和学术机构, 诊断中心)
  • What is the historic period, base year, and forecast period taken for South and Central America Circulating Tumor Cell (CTC) Diagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Circulating Tumor Cell (CTC) Diagnostics Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in South and Central America Circulating Tumor Cell (CTC) Diagnostics Market?

    The South and Central America Circulating Tumor Cell (CTC) Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Thermo Fisher Scientific Inc.
  • Stemcell Technologies Inc.
  • Qiagen
  • Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
  • Fluxion Biosciences
  • Who should buy this report?

    The South and Central America Circulating Tumor Cell (CTC) Diagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South and Central America Circulating Tumor Cell (CTC) Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.